|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
08247 BIOSINO BIO-TEC
Nominal 
3.620 -0.080 (-2.162%) | 2025/12 - Final RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | (25,841) | 23,751 | (6,560) | 44,529 | 48,894 |
| Net Cash from / (used in) Investing Activities | (4,546) | (11,846) | (17,700) | (1,117) | (5,778) |
| Net Cash from / (used in) Financing Activities | 5,760 | (7,051) | 10,249 | (10,756) | (44,022) |
| Increase / (Decrease) in Cash & Cash Equivalents | (24,627) | 4,854 | (14,011) | 32,656 | (906) |
| Cash & Cash Equivalents at beginning of period | 68,213 | 63,410 | 77,349 | 44,469 | 45,453 |
| Effect of Foreign Exchange Rate Changes | (66) | (51) | 72 | 224 | (78) |
| Others | 0 | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | 43,520 | 68,213 | 63,410 | 77,349 | 44,469 |
| Remarks: | Real time quote last updated: 13/04/2026 14:55 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -51,142 |
| %Change | 20.244% |
| EPS / (LPS) | RMB -0.353 |
| NBV Per Share (¥) | RMB 0.831 |